2.48

6.90% 0.16

After Hours: 2.48

Hookipa Pharma Inc (HOOK)

Overview News Price History Option Chain Financials Discussions Forecast

Hookipa Pharma Inc stock is traded at $2.48, with a volume of 62,764. It is up +6.90% in the last 24 hours and down -34.39% over the past month. HOOKIPA Pharma Inc is a clinical stage biopharmaceutical company developing a class of immunotherapeutics targeting infectious diseases and cancers based on its proprietary arenavirus platform that is designed to reprogram the body's immune system. It uses off-the-shelf technologies, VaxWave and TheraT, to elicit directly within patients a response of antigen-specific killer T cells and antibodies.

Previous Close:

$2.32

Open:

$2.39

24h Volume:

62,764

Relative Volume:

1.46

Market Cap:

$28.21M

Revenue:

$52.16M

Net Income/Loss:

$-48.60M

P/E Ratio:

-2.7253

EPS:

-0.91

Net Cash Flow:

$-77.48M

1W Performance:

-8.82%

1M Performance:

-34.39%

6M Performance:

-69.00%

1Y Performance:

-51.71%

1-Day Range:

$2.3308

$2.50

1-Week Range:

$2.08

$2.75

52-Week Range:

$2.08

$11.30

Hookipa Pharma Inc Stock (HOOK) Company Profile

Name

Hookipa Pharma Inc

Sector

Healthcare (1200)

Industry

Biotechnology (682)

Phone

0114318906360

Address

350 FIFTH AVENUE, 72ND FLOOR, SUITE 7240, NEW YORK, NY

Employee

124

Twitter

@HookipaPharma

Next Earnings Date

2024-11-07

Latest SEC Filings

HOOK's Discussions on Twitter

Compare HOOK with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
HOOK Hookipa Pharma Inc	2.48	28.21M	52.16M	-48.60M	-77.48M	-0.91
VRTX Vertex Pharmaceuticals Inc	464.56	119.70B	10.63B	-479.80M	-1.35B	13.33
REGN Regeneron Pharmaceuticals Inc	754.87	82.75B	13.85B	4.65B	3.32B	35.06
ARGX Argen X Se Adr	614.59	36.73B	1.86B	-40.29M	-1.28B	-4.16
ALNY Alnylam Pharmaceuticals Inc	253.74	32.53B	2.09B	-332.26M	16.06M	-4.14
BNTX Biontech Se Adr	120.72	28.50B	3.30B	-501.07M	1.03B	11.54

Hookipa Pharma Inc Stock (HOOK) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Nov-15-24	Reiterated	RBC Capital Mkts	Outperform
Dec-02-22	Downgrade	BofA Securities	Buy → Underperform
Nov-12-21	Downgrade	Morgan Stanley	Overweight → Equal-Weight
Apr-08-21	Initiated	Morgan Stanley	Overweight
Nov-03-20	Initiated	Truist	Buy
Oct-26-20	Initiated	JMP Securities	Mkt Outperform
Oct-19-20	Resumed	H.C. Wainwright	Buy
Sep-27-19	Initiated	H.C. Wainwright	Buy
May-13-19	Initiated	BofA/Merrill	Buy
May-13-19	Initiated	RBC Capital Mkts	Outperform

View All

Hookipa Pharma Inc Stock (HOOK) Latest News

Nov 26, 2024

HOOKIPA Pharma's SWOT analysis: stock faces challenges amid pipeline shifts - Investing.com

Nov 26, 2024

Nov 25, 2024

HOOK (HOOKIPA Pharma) GF Value Rank : 2 (As of Nov. 25, 2024) - GuruFocus.com

Nov 25, 2024

HOOK (HOOKIPA Pharma) Debt-to-Equity : 0.04 (As of Sep. 2024) - GuruFocus.com

Nov 25, 2024

JMP Securities Has Lowered Expectations for Hookipa Pharma (NASDAQ:HOOK) Stock Price - Defense World

Nov 25, 2024

Nov 22, 2024

Hookipa Pharma price target lowered to $7 from $24 at JMP Securities - Yahoo Finance

Nov 22, 2024

Hookipa Pharma announces workforce reduction of 80%, pause of eseba-vec program - Yahoo Finance

Nov 22, 2024

Hookipa Pharma stock hits 52-week low at $2.62 amid market challenges By Investing.com - Investing.com South Africa

Nov 22, 2024

Nov 21, 2024

Hookipa Pharma stock hits 52-week low at $2.62 amid market challenges - Investing.com

Nov 21, 2024

Nov 19, 2024

Companies Like HOOKIPA Pharma (NASDAQ:HOOK) Could Be Quite Risky - Simply Wall St

Nov 19, 2024

Nov 17, 2024

HOOKIPA Pharma Third Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag - Yahoo Finance

Nov 17, 2024

Nov 15, 2024

HOOKIPA Pharma stock target lowered, maintains outlook on strategic direction - Investing.com

Nov 15, 2024

RBC Capital Mkts reiterated coverage on HOOKIPA Pharma with a new price target - Quantisnow

Nov 15, 2024